ATHE ALTERITY THERAPEUTICS LTD
Price Chart
Executive Summary
Alterity Therapeutics completed a 50-to-1 reverse stock split, reducing outstanding ordinary shares to 217,508,862. The consolidation was approved by shareholders on May 29, 2026, and normal trading commenced June 12, 2026. This is a routine capital structure adjustment with no change to the company's fundamental value or business operations.
Actionable Insight
The reverse split is a mechanical adjustment with no fundamental impact. Monitor for any Nasdaq compliance updates or subsequent capital-raising activities that may follow the consolidation.
Key Facts
- Reverse stock split completed on a 50-to-1 basis, effective June 12, 2026
- Post-consolidation ordinary shares: 217,508,862
- Shareholder approval obtained at General Meeting on May 29, 2026
- Fractional entitlements rounded up to nearest whole number
- Normal trading commenced June 12, 2026 on ASX under code ATH
Financial Impact
No financial impact — reverse split adjusts share price proportionally without changing market capitalization or enterprise value
Risk Factors
- Reverse splits can signal financial distress or listing compliance issues, though the filing does not cite any specific deficiency
- Post-split share price may face selling pressure from retail holders adjusting to the new nominal price
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-020373 |
| Document: athe20260612_6k.htm | 0001437749-26-020373 |
| Document: 0001437749-26-020373-index-headers.html | 0001437749-26-020373 |
| Document: 0001437749-26-020373-index.html | 0001437749-26-020373 |
| Document: 0001437749-26-020373.txt | 0001437749-26-020373 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
1d ago
|
6-K
| $4.15 awaiting T+5 | awaiting T+5 | — | $4.21 (+1.57%) |
|
Jun 9, 2026
4d ago
|
Press Release
| $3.92 awaiting T+5 | awaiting T+5 | — | $4.21 (+7.40%) |
|
May 11, 2026
4w ago
|
Press Release
| $4.80 $4.34 | ▼ −9.58% | ▼ −9.50% | $4.21 (−12.29%) |
|
Apr 30, 2026
6w ago
|
Press Release
| $4.54 $4.67 | ▲ +2.86% | ▲ +1.14% | $4.21 (−7.27%) |
|
Apr 27, 2026
6w ago
|
Press Release
| $4.62 $4.52 | ▼ −2.16% | ▼ −2.56% | $4.21 (−8.87%) |
|
Apr 22, 2026
7w ago
|
Press Release
| $4.54 $4.57 | ▲ +0.66% | ▲ +0.61% | $4.21 (−7.27%) |
|
Mar 26, 2026
11w ago
|
6-K
| $3.16 $3.56 | ▲ +12.66% | ▲ +11.02% | $4.21 (+33.23%) |
|
Mar 2, 2026
14w ago
|
Press Release
| $3.45 $3.55 | ▲ +2.90% | ▲ +4.11% | $4.21 (+22.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access